secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001425450-26-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics reports record 2025 revenue $236.3M (+15% YoY); Q4 first positive free cash flow $9.8M
--------------------------------------------------------------------------------

- Record FY2025 revenue $236.3M, up 15% from $204.7M in 2024.
- Q4 2025 revenue $61.6M (+17% YoY); net loss per share $0.43 vs $0.69.
- Adjusted EBITDA FY2025 $14.8M vs $8.5M; Q4 adjusted EBITDA $4.8M vs $3.0M.
- Generated $9.8M free cash flow in Q4, first positive FCF quarter; cash $62.9M.
- FY2026 guidance: revenue $262-266M (11-13% growth), adjusted EBITDA ~$25M, breakeven cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/0001425450-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/kids-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001425450-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer